Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

562 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
ANMCO Position Paper: direct oral anticoagulants for stroke prevention in atrial fibrillation: clinical scenarios and future perspectives.
Nardi F, Gulizia MM, Colivicchi F, Abrignani MG, Di Fusco SA, Di Lenarda A, Di Tano G, Geraci G, Moschini L, Riccio C, Verdecchia P, Enea I. Nardi F, et al. Among authors: verdecchia p. Eur Heart J Suppl. 2017 May;19(Suppl D):D70-D88. doi: 10.1093/eurheartj/sux007. Epub 2017 May 2. Eur Heart J Suppl. 2017. PMID: 28751836 Free PMC article.
[ANMCO statement on prevention of thromboembolism in atrial fibrillation and role of the new oral anticoagulants].
Colonna P, Abrignani MG, Colivicchi F, Verdecchia P, Alunni G, Bongo AS, Ceravolo R, Oliva F, Rakar S, Riccio C, Scherillo M, Valle R, Bovenzi F; Associazione Nazionale Medici Cardiologi Ospedalieri (ANMCO). Colonna P, et al. Among authors: verdecchia p. G Ital Cardiol (Rome). 2013 Apr;14(4):295-322. doi: 10.1714/1257.13889. G Ital Cardiol (Rome). 2013. PMID: 23567775 Italian.
[ANMCO Position paper: Direct new oral anticoagulants for the prevention of thromboembolic complications in patients with atrial fibrillation: clinical scenarios and future perspectives].
Nardi F, Gulizia MM, Colivicchi F, Abrignani MG, Di Fusco SA, Di Lenarda A, Di Tano G, Moschini L, Riccio C, Verdecchia P, Enea I. Nardi F, et al. Among authors: verdecchia p. G Ital Cardiol (Rome). 2016 Sep;17(9 Suppl 1):3S-28. doi: 10.1714/2450.25666. G Ital Cardiol (Rome). 2016. PMID: 27869891 Italian.
Persistence on apixaban in atrial fibrillation patients: a retrospective multicentre study.
Verdecchia P, D'Onofrio A, Russo V, Fedele F, Adamo F, Benedetti G, Ferrante F, Lodigiani C, Paciullo F, Aita A, Bartolini C, Molini MG, Di Lenarda A, Mazzone C, Scotti L, Lanati EP, Iorio A. Verdecchia P, et al. J Cardiovasc Med (Hagerstown). 2019 Feb;20(2):66-73. doi: 10.2459/JCM.0000000000000744. J Cardiovasc Med (Hagerstown). 2019. PMID: 30540644
Correction to: Comparative effectiveness and safety of non-vitamin K antagonists for atrial fibrillation in clinical practice: GLORIA-AF Registry.
Lip GYH, Kotalczyk A, Teutsch C, Diener HC, Dubner SJ, Halperin JL, Ma CS, Rothman KJ, Marler S, Gurusamy VK, Huisman MV; GLORIA-AF Investigators. Lip GYH, et al. Clin Res Cardiol. 2022 May;111(5):593. doi: 10.1007/s00392-022-02021-2. Clin Res Cardiol. 2022. PMID: 35384487 Free PMC article. No abstract available.
Predictors of early-stage left ventricular dysfunction in type 2 diabetes: results of DYDA study.
Giorda CB, Cioffi G, de Simone G, Di Lenarda A, Faggiano P, Latini R, Lucci D, Maggioni AP, Tarantini L, Velussi M, Verdecchia P, Comaschi M; DYDA Investigators. Giorda CB, et al. Among authors: verdecchia p. Eur J Cardiovasc Prev Rehabil. 2011 Jun;18(3):415-23. doi: 10.1177/1741826710389402. Epub 2011 Feb 22. Eur J Cardiovasc Prev Rehabil. 2011. PMID: 21450640
Analysis of midwall shortening reveals high prevalence of left ventricular myocardial dysfunction in patients with diabetes mellitus: the DYDA study.
Cioffi G, Giorda CB, Chinali M, Di Lenarda A, Faggiano P, Lucci D, Maggioni AP, Masson S, Mureddu GF, Tarantini L, Velussi M, Comaschi M; DYDA Investigators. Cioffi G, et al. Eur J Prev Cardiol. 2012 Oct;19(5):935-43. doi: 10.1177/1741826711417759. Epub 2011 Jul 28. Eur J Prev Cardiol. 2012. PMID: 21798988
Inappropriately high left ventricular mass in patients with type 2 diabetes mellitus and no overt cardiac disease. The DYDA study.
Cioffi G, Faggiano P, Lucci D, Di Lenarda A, Mureddu GF, Tarantini L, Verdecchia P, Comaschi M, Giorda CB, Velussi M, Chinali M, Latini R, Masson S, De Simone G; DYDA Investigators. Cioffi G, et al. Among authors: verdecchia p. J Hypertens. 2011 Oct;29(10):1994-2003. doi: 10.1097/HJH.0b013e32834acc6d. J Hypertens. 2011. PMID: 21881524
562 results